Newron Pharmaceuticals S.p.A. insider transactions
Management transactions
11
Shareholding disclosures
111
First disclosure
07.12.2006
Last disclosure
12.08.2026
Company summary
Over 90 days: 3 purchases (CHF 58 k) and 0 sales (CHF 0.00). Disclosed flows are net buying.
- Latest purchase
- CHF 10’781
- Net flow 90 d
- CHF 58’355
- Top shareholder
- 18.267%
08.10.2026 · Executive member of the board of directors / senior management
Buys − sales
Newron Pharmaceuticals SpA
This page brings together all Newron Pharmaceuticals S.p.A. (NEWRONPH) insider transactions: 11 management transactions and 111 significant shareholding disclosures published by SIX Exchange Regulation, from 07.12.2006 to 12.08.2026.
Detailed context
The platform provides a comprehensive overview of Newron Pharmaceuticals S.p.A. regarding insider transactions and significant shareholding disclosures published by SIX Exchange Regulation. To date, there have been 11 management transactions and 111 significant shareholding notifications, with the latest management transaction occurring on 2026-10-08. During the last 90 days, there were 3 purchases totaling CHF 58'355 and 0 sales. The largest declared shareholders by voting rights include Newron Pharmaceuticals SpA with 18.267%, NEWRON PHARMCEUTICALS SPA with 18.343%, FARIELLO RUGGERO with 16.1%, and DOLPHIN SPA with 15.9%.
Insider barometer
90 days
3 transactionsCHF 58’355
Net buying
Declared purchases
CHF 58’355
Declared sales
CHF 0.00
Latest transaction
08.10.2026
Largest purchase
CHF 53’666
Largest sale
CHF 247’984
These figures aggregate public disclosures. They are not investment advice.
insider24.ch
Follow Newron Pharmaceuticals S.p.A.’s disclosures
Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.
Need more? Discover the Pro plan
Newron Pharmaceuticals S.p.A. insider transactions
Newron Pharmaceuticals S.p.A.
Executive member of the board of directors / senior management · Registered shares
Newron Pharmaceuticals S.p.A.
Executive member of the board of directors / senior management · Registered shares
Newron Pharmaceuticals S.p.A.
Executive member of the board of directors / senior management · Registered shares
Newron Pharmaceuticals S.p.A.
Non-executive member of the board of directors · Registered shares
Newron Pharmaceuticals S.p.A.
Non-executive member of the board of directors · Registered shares
Newron Pharmaceuticals S.p.A.
Non-executive member of the board of directors · Registered shares
Newron Pharmaceuticals S.p.A.
Executive member of the board of directors / senior management · Registered shares
Newron Pharmaceuticals S.p.A.
Executive member of the board of directors / senior management · Registered shares
Newron Pharmaceuticals S.p.A.
Non-executive member of the board of directors · Registered shares
Newron Pharmaceuticals S.p.A.
Non-executive member of the board of directors · Registered shares
Latest shareholding disclosures
Newron Pharmaceuticals S.p.A.
UBS Fund Management Switzerland AG · Collective investment vehicle
Newron Pharmaceuticals S.p.A.
UBS Fund Management Switzerland AG · Collective investment vehicle
Newron Pharmaceuticals S.p.A.
6 people · Raghupati Singhania…
Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals SpA · Single shareholder
Newron Pharmaceuticals S.p.A.
Tobias Scherer · Single shareholder